|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/20 | |
| A61P 35/00 | |||
| A61P 35/04 |
| (11) | Number of the document | 1846020 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06719806.9 |
| Date of filing the European patent application | 2006-01-27 | |
| (97) | Date of publication of the European application | 2007-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2013-08-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/003116 |
| Date | 2006-01-27 |
| (87) | Number | WO 2006/081510 |
| Date | 2006-08-03 |
| (30) | Number | Date | Country code |
| 647496 P | 2005-01-27 | US |
| (72) |
ELIAS, Laurence, Chiron Corporation, US
WITHERELL, Gary, Chiron Corporation, US
|
| (73) |
Novartis Vaccines and Diagnostics, Inc.,
Intellectual Property - R440 P.O. Box 8097, Emeryville, CA 94662-8097,
US
|
| (54) | METHODS FOR TREATING RENAL CELL CARCINOMA |
| METHODS FOR TREATING RENAL CELL CARCINOMA |